In-vitro activity of dirithromycin against Chlamydia pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 5, 1997, Pages 647-649

  Roblin, Patricia M ^a   Kutlin, Andrei ^a   Sokolovskaya, Natasha ^a   Hammerschlag, Margaret R ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIRITHROMYCIN; ERYTHROMYCIN; ERYTHROMYCYLAMINE; MACROLIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; CHLAMYDIA TRACHOMATIS; ERYTHROMYCIN; MACROLIDES; MICROBIAL SENSITIVITY TESTS;

EID: 0031011153     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.5.647     Document Type: Article

References (11)

1. Brogden, R. N. & Peters, D. H. (1994). Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 48, 599-616.
2. Anonymous. (1995). Dirithromycin. Medical Letter on Drugs and Therapeutics 37, 109-110.
3. Grayston, J. T., Campbell, L. A., Kuo, C. C., Mordhorst, C. H., Saikku, P., Thom, D. H. et al. (1990). A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. Journal of Infectious Diseases 161, 618-25.
4. Block, S., Hedrick, J., Hammerschlag, M. R., Cassell, G. H. & Craft, J. C. (1995). Mycoplasma pneumoniae and Chiamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatric Infectious Disease Journal 14, 471-7.
5. Roblin, P. M., Montalban, G. & Hammerschlag, M. R. (1994). Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. Antimicrobial Agents and Chemotherapy 38, 1588-9.
6. Emre, U., Roblin, P. M., Gelling, M., Dumornay, W., Rao, M., Hammerschlag, M. R. et al. (1994). The association of Chiamydia pneumoniae infection and reactive airway disease in children. Archives of Pediatrics and Adolescent Medicine 148, 727-32.
7. Rennie, K. A., Prasad, E. S. & Wenman, W. N. (1994). In vitro activity of dirithromycin, a new macrolide antibiotic, against Mycoplasma species. Diagnostic Microbiology and Infectious Diseases 20, 57-9.
8. Segreti, J. & Kapell, K. S. (1994). In vitro activity of dirithromycin against Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 38, 2213-4.
9. Jacobson, K. (1993). Clinical efficacy of dirithromycin in pneumonia. Journal of Antimicrobial Chemotherapy 31, Suppl. C, 121-9.
10. Sides, G. D. (1993). Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy 31, Suppl. C, 131-8.
11. Liippo, K., Tala, E., Puolijoki, H., Bruckner, O. J., Rodrig, J. & Smits, J. P. (1994). A comparative study of dirithromycin and erythromycin in bacterial pneumonia. Journal of Infection 28, 131-9.